1f
12
9
1a
8
20
8
49
16
8
19
1
49
2
8
1b
1d
18
89
4f
1d
2 29
1d
25
4f
Katheryn Alexandra Quilico Cousins-Gershenson, PhD
4eResearch Assistant Professor of Neurology
7
60
Department: Neurology
4
1
b
1d
46
Contact information
54
4
3
23
54
Richards Medical Building, Suite 600B
35 3700 Hamilton Walk
Philadelphia, PA 19104
26
35 3700 Hamilton Walk
Philadelphia, PA 19104
35
af
12
1f
Graduate Group Affiliations
8
3
3
2
4
b
1f
-
64
- Neuroscience e
13
Education:
21 7 BA 21 ( Biological Sciences) c
2e University of Chicago, 2007.
21 8 PhD 19 (Neuroscience) c
2c Brandeis University, 2015.
c
3
3
21
21 7 BA 21 ( Biological Sciences) c
2e University of Chicago, 2007.
21 8 PhD 19 (Neuroscience) c
2c Brandeis University, 2015.
c
1f
Post-Graduate Training
24 5a Postdoctoral Fellow in Neurology, University of Pennsylvania, 2014-2018.
24 5a Postdoctoral Research in Neuroscience, Washington University, 2018-2019.
c
3
3
8d
Permanent link24 5a Postdoctoral Fellow in Neurology, University of Pennsylvania, 2014-2018.
24 5a Postdoctoral Research in Neuroscience, Washington University, 2018-2019.
c
2 29
21
1e
1d
24
76
e 29
27
Description of Research Expertise
32 Biofluid markers of neuropathologye 29
23
133 Rhodes, Cousins, Philips, Lee, Wolk & McMillan: Progressive amnestic syndrome in the absence of AD biomarkers and TDP-43 pathology: Primary age-related tauopathy as a clinical mimic of limbic-predominant age-related TDP-43 encephalopathy. Invited Talk, 6a National Alzheimer’s Coordinating Center (NACC)/ADRC LATE webinar series April 2026.
203 Honey, Thijssen, Hok-A-Hin, Cousins, Weijden, Veld, Stoops, de Boer, Duits, Houwer, Morrema, Alcolea, Illán-Gala, Fortea, Lleó, Boxer, Irwin, Lee, Shaw, McMillan, Wolk, Hoozemans, van der Flier, van der Ende, Seelaar, Verberk, Gan, Pijnenburg, Teunissen: An Acetylated Tau-174 CSF Biomarker Discriminates Between TDP-43 and Tau Pathology in Patients with Frontotemporal Degeneration. Invited Talk: Restoring Neural Resilience in ALS and Alzheimer’s Disease 51 Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.
176 Cousins, Boyle, Morse, Verma, Brown, O’Brien, Serper, Dehghani, Penn Medicine BioBank, McMillan, Lee, Shaw, & Wolk: Electronic health records to test multimorbidity influences to plasma biomarker interpretation for Alzheimer’s disease. Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.
187 Simrén, Rönnholm, Weiner, Pola, Benedet, Shaw, Wolk, Weintraub, Lee, McMillan, Blennow, Irwin, Zetterberg*, Gobom*, & Cousins*: Cerebrospinal fluid proteomic profiling in frontotemporal lobar degeneration, Alzheimer’s disease and Lewy body disease. Invited Talk: Biomarker Signatures in Preclinical AD and Neurodegenerative Diseases 51 Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.
1d4 Brown CA, Mundada NS, Cousins KAQ, Sadeghpour N, Lyu X, McGrew E, Korecka M, Chen-Plotkin A, Xie L, Wisse LEM, Detre JA, McMillan CT, Lee EB, Nasrallah IM, Das SR, Mechanic-Hamilton D, Yushkevich PA, Shaw LM, Wolk DA; Alzheimer’s Disease Neuroimaging Initiative.: Evaluation of Copathology and Clinical Trajectories in Individuals With Tau-Clinical Mismatch. JAMA Neurol 83: 126-136, Feb 2026.
168 Cousins KAQ, Boyle R, Morse C, Verma A, Brown CA, O'Brien KS, Serper M, Dehghani N; Penn Medicine BioBank; McMillan CT, Lee EB, Shaw LM, Wolk DA.: Electronic Health Records to Test Multimorbidity Influences to Plasma Biomarker Interpretation for Alzheimer's Disease. Ann Neurol Dec 2025.
84 Kwiecinski, Dratch, Andrews, Dengel, Kamel, Legaspi, McMillan, Massimo, Cousins, & Irwin d4 : Evaluating the Impact of Predictive Genetic Counseling in Frontotemporal Dementia: A Pilot Analysis. National Society of Genetic Counselors (NSGC) 44th Annual Conference Nov 2025.
7b Ohm, Capp, Sabitini, Cousins, Phillips, Rascovsky, Wolk, Lee, McMillan, & Irwin 2 a1 : Selectively vulnerable myeloarchitecture in behavioral variant frontotemporal dementia. Society for Neuroscience (SfN) Nov 2025.
16f Luna, Cousins, Emrani, Luk, Lee, Lee, Weintraub, Xie, Chen-Plotkin, Bennett, & Irwin: Lewy Pathology correlates with neuroinflammation in the hippocampus of Synucleinopathy patients in a subregion specific manner. International Congress of Parkinson’s Disease and Movement Disorders Oct 2025.
2c
7
1d
1f
Selected Publications
145 Elser, Cousins, Gee, Boyle, Massimo, Brown, Shaw, Lee, Weisskopf, McMillan, & Wolk: Long-term air pollution exposure and Alzheimer disease biofluid biomarkers. National Alzheimer’s Coordinating Center (NACC) Spring ADRC Meeting, Atlanta, GA May 2026.133 Rhodes, Cousins, Philips, Lee, Wolk & McMillan: Progressive amnestic syndrome in the absence of AD biomarkers and TDP-43 pathology: Primary age-related tauopathy as a clinical mimic of limbic-predominant age-related TDP-43 encephalopathy. Invited Talk, 6a National Alzheimer’s Coordinating Center (NACC)/ADRC LATE webinar series April 2026.
203 Honey, Thijssen, Hok-A-Hin, Cousins, Weijden, Veld, Stoops, de Boer, Duits, Houwer, Morrema, Alcolea, Illán-Gala, Fortea, Lleó, Boxer, Irwin, Lee, Shaw, McMillan, Wolk, Hoozemans, van der Flier, van der Ende, Seelaar, Verberk, Gan, Pijnenburg, Teunissen: An Acetylated Tau-174 CSF Biomarker Discriminates Between TDP-43 and Tau Pathology in Patients with Frontotemporal Degeneration. Invited Talk: Restoring Neural Resilience in ALS and Alzheimer’s Disease 51 Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.
176 Cousins, Boyle, Morse, Verma, Brown, O’Brien, Serper, Dehghani, Penn Medicine BioBank, McMillan, Lee, Shaw, & Wolk: Electronic health records to test multimorbidity influences to plasma biomarker interpretation for Alzheimer’s disease. Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.
187 Simrén, Rönnholm, Weiner, Pola, Benedet, Shaw, Wolk, Weintraub, Lee, McMillan, Blennow, Irwin, Zetterberg*, Gobom*, & Cousins*: Cerebrospinal fluid proteomic profiling in frontotemporal lobar degeneration, Alzheimer’s disease and Lewy body disease. Invited Talk: Biomarker Signatures in Preclinical AD and Neurodegenerative Diseases 51 Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.
1d4 Brown CA, Mundada NS, Cousins KAQ, Sadeghpour N, Lyu X, McGrew E, Korecka M, Chen-Plotkin A, Xie L, Wisse LEM, Detre JA, McMillan CT, Lee EB, Nasrallah IM, Das SR, Mechanic-Hamilton D, Yushkevich PA, Shaw LM, Wolk DA; Alzheimer’s Disease Neuroimaging Initiative.: Evaluation of Copathology and Clinical Trajectories in Individuals With Tau-Clinical Mismatch. JAMA Neurol 83: 126-136, Feb 2026.
168 Cousins KAQ, Boyle R, Morse C, Verma A, Brown CA, O'Brien KS, Serper M, Dehghani N; Penn Medicine BioBank; McMillan CT, Lee EB, Shaw LM, Wolk DA.: Electronic Health Records to Test Multimorbidity Influences to Plasma Biomarker Interpretation for Alzheimer's Disease. Ann Neurol Dec 2025.
84 Kwiecinski, Dratch, Andrews, Dengel, Kamel, Legaspi, McMillan, Massimo, Cousins, & Irwin d4 : Evaluating the Impact of Predictive Genetic Counseling in Frontotemporal Dementia: A Pilot Analysis. National Society of Genetic Counselors (NSGC) 44th Annual Conference Nov 2025.
7b Ohm, Capp, Sabitini, Cousins, Phillips, Rascovsky, Wolk, Lee, McMillan, & Irwin 2 a1 : Selectively vulnerable myeloarchitecture in behavioral variant frontotemporal dementia. Society for Neuroscience (SfN) Nov 2025.
16f Luna, Cousins, Emrani, Luk, Lee, Lee, Weintraub, Xie, Chen-Plotkin, Bennett, & Irwin: Lewy Pathology correlates with neuroinflammation in the hippocampus of Synucleinopathy patients in a subregion specific manner. International Congress of Parkinson’s Disease and Movement Disorders Oct 2025.
2c